x

Merck says OTC overactive bladder patch cleared

Print Page Updated: 06:42:40 PM, Fri 25 January 2013
WHITEHOUSE STATION, N.J. (AP) — Merck & Co. said Friday it received approval to market the overactive bladder patch Oxytrol over the counter.

Oxytrol has been on the market since 2003 as a treatment for overactive bladder in women. Merck gained the right to sell the over-the-counter version from Actavis Inc., which makes the original version.

Shares of Merck rose 6 cents to $43.06 in afternoon trading. Shares of Actavis fell $2.30, or 2.7 percent, to $84.13 after the company issued a disappointing 2013 forecast. Actavis changed its name from Watson Pharmaceuticals on Thursday.

Tags: ap, merck, watson pharmaceuticals, actavis, actavis inc., cents, health, over-the-counter drug, thursday, women, n.j., new jersey, percent, afternoon trading, friday, co., pharmaceutical companies of the united states, stock, forecast, treatment, right, stock market, shares, approval, whitehouse station, bladder patch oxytrol, overactive bladder, overactive bladder patch, otc overactive bladder, over-the-counter version, original version, readington township, new jersey

Close
Loading

News Headlines.com

  • List View
  • Grid View
Close
Contact Us
Send Feedback X